From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
|Podcasts|September 9, 2022
Pharmacy Focus: Psychedelic Pharmacy - Understanding Synthetic vs. Natural Psychedelics
Scientists may be able to minimize adverse effects while gaining a better understanding of psychedelic medicines' efficacy and durability.
Advertisement
This month, we spoke with Joseph Araujo, co-founder, director, and chief scientific officer at Mindset Pharma, to get an overview of the differences between synthetic and natural psychedelic medicines. By developing synthetic versions of natural medicines, scientists may be able to minimize adverse effects while gaining a better understanding of their efficacy and durability.
Advertisement
Related to this article
From insurance delays to injection concerns, pharmacists can help patients navigate the first month and avoid preventable treatment interruptions.
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
A disease-modifying therapy for stage 3 T1D, a second once-weekly insulin, and automated insulin delivery for T2D mark a busy year in diabetes care.
Before lung cancer therapy begins, diagnostic findings and treatment readiness shape care, creating opportunities for pharmacists to help patients start safely.
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Happens Before the First Dose? 5 Steps That Shape Lung Cancer Treatment
2
Diabetes Awareness Month Opens Amid New T1D, T2D Approvals
3
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
4
Full IDWeek Data Highlights 31-Valent Pneumococcal Conjugate Vaccine Candidate in Adults
5